Pembrolizumab
CCR 4268
Phase 1 other terminated
Quick answer
Pembrolizumab for Cervix Cancer is a Phase 1 program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Cervix Cancer
- Phase
- Phase 1
- Modality
- other
- Status
- terminated